<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38503738</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study.</ArticleTitle><Pagination><StartPage>2444</StartPage><MedlinePgn>2444</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2444</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-46692-z</ELocationID><Abstract><AbstractText>There have been reports of long coronavirus disease (long COVID) and breakthrough infections (BTIs); however, the mechanisms and pathological features of long COVID after Omicron BTIs remain unclear. Assessing long-term effects of COVID-19 and immune recovery after Omicron BTIs is crucial for understanding the disease and managing new-generation vaccines. Here, we followed up mild BA.2 BTI convalescents for six-month with routine blood tests, proteomic analysis and single-cell RNA sequencing (scRNA-seq). We found that major organs exhibited ephemeral dysfunction and recovered to normal in approximately six-month after BA.2 BTI. We also observed durable and potent levels of neutralizing antibodies against major circulating sub-variants, indicating that hybrid humoral immunity stays active. However, platelets may take longer to recover based on proteomic analyses, which also shows coagulation disorder and an imbalance between anti-pathogen immunity and metabolism six-month after BA.2 BTI. The immunity-metabolism imbalance was then confirmed with retrospective analysis of abnormal levels of hormones, low blood glucose level and coagulation profile. The long-term malfunctional coagulation and imbalance in the material metabolism and immunity may contribute to the development of long COVID and act as useful indicator for assessing recovery and the long-term impacts after Omicron sub-variant BTIs.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Yanhua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Qin</LastName><ForeName>Shijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatrics, Shenzhen Children's Hospital, Shenzhen, 518026, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dong</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Air Force Medical Center, 100142, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Qiao</LastName><ForeName>Shitong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, 101408, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Yunnan University, Kunming, 650091, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dongshan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, 330008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Pengyue</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shanxi Academy of Advanced Research and Innovation, Taiyuan, 030032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quan</LastName><ForeName>Shouzhen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Air Force Medical Center, 100142, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Air Force Medical Center, 100142, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Fengyan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Air Force Medical Center, 100142, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2001-1343</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China. zhaoxin@im.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, 101408, Beijing, China. zhaoxin@im.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Life Science Academy, 102209, Beijing, China. zhaoxin@im.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yueyun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Air Force Medical Center, 100142, Beijing, China. mayueyun2020@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>George Fu</ForeName><Initials>GF</Initials><Identifier Source="ORCID">0000-0002-3869-615X</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 100101, Beijing, China. gaof@im.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, 101408, Beijing, China. gaof@im.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanxi Academy of Advanced Research and Innovation, Taiyuan, 030032, China. gaof@im.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023M743729</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country/></Grant><Grant><GrantID>2022M723344</GrantID><Agency>China Postdoctoral Science Foundation</Agency><Country/></Grant><Grant><GrantID>82222040</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country/></Grant><Grant><GrantID>82170004</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country/></Grant><Grant><GrantID>2020092</GrantID><Agency>Youth Innovation Promotion Association of the Chinese Academy of Sciences (Youth Innovation Promotion Association CAS)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093742" MajorTopicYN="Y">Breakthrough Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>0</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38503738</ArticleId><ArticleId IdType="pmc">PMC10951309</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-46692-z</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-46692-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Timeline: WHO&#x2019;s COVID-19 response. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline (2022).</Citation></Reference><Reference><Citation>Kandeel M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, El-Beltagi HS. Omicron variant genome evolution and phylogenetics. J. Med. Virol. 2022;94:1627&#x2013;1632. doi: 10.1002/jmv.27515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27515</ArticleId><ArticleId IdType="pmc">PMC9015349</ArticleId><ArticleId IdType="pubmed">34888894</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct. Target Ther. 2022;7:141. doi: 10.1038/s41392-022-00997-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00997-x</ArticleId><ArticleId IdType="pmc">PMC9047469</ArticleId><ArticleId IdType="pubmed">35484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J. Med. Virol. 2022;94:1641&#x2013;1649. doi: 10.1002/jmv.27526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27526</ArticleId><ArticleId IdType="pubmed">34914115</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID- 19 Clinical and Surveillance Data--Dec 9, 2022 to Jan 23, 2023, China. https://en.chinacdc.cn/news/latest/202301/t20230126_263523.html (2023).</Citation></Reference><Reference><Citation>GISAID - NextStrain. https://gisaid.org/phylodynamics/global/nextstrain/ (2023).</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Long COVID or Post-COVID Conditions. Centers for Disease Control and Preventionhttps://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (2023).</Citation></Reference><Reference><Citation>Thaweethai T, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah F, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int. J. Infect. Dis. 2022;116:38&#x2013;42. doi: 10.1016/j.ijid.2021.12.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.12.357</ArticleId><ArticleId IdType="pmc">PMC8713416</ArticleId><ArticleId IdType="pubmed">34971823</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N, et al. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat. Commun. 2022;13:5860. doi: 10.1038/s41467-022-33614-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33614-0</ArticleId><ArticleId IdType="pmc">PMC9531215</ArticleId><ArticleId IdType="pubmed">36195617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter N, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399:437&#x2013;446. doi: 10.1016/S0140-6736(22)00017-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00017-4</ArticleId><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg. Microbes Infect. 2023;12:2220578. doi: 10.1080/22221751.2023.2220578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220578</ArticleId><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Muik A, et al. Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5. Sci. Immunol. 2022;7:eade2283. doi: 10.1126/sciimmunol.ade2283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.ade2283</ArticleId><ArticleId IdType="pmc">PMC9529054</ArticleId><ArticleId IdType="pubmed">36125366</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan, P. China&#x2019;s COVID-19 Vaccine Supplies to the Global South: Between Politics and Business (Policy Press, 2022).</Citation></Reference><Reference><Citation>Government orders 4.3 million further doses of COVID-19 antivirals. Pharm. J. 10.1211/pj.2021.1.121425 (2021).</Citation></Reference><Reference><Citation>Zhu F-C, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395:1845&#x2013;1854. doi: 10.1016/S0140-6736(20)31208-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31208-3</ArticleId><ArticleId IdType="pmc">PMC7255193</ArticleId><ArticleId IdType="pubmed">32450106</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-X, et al. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. Lancet Respir. Med. 2022;10:739&#x2013;748. doi: 10.1016/S2213-2600(22)00087-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00087-X</ArticleId><ArticleId IdType="pmc">PMC9122540</ArticleId><ArticleId IdType="pubmed">35605625</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, et al. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int. J. Biol. Sci. 2021;17:1497&#x2013;1506. doi: 10.7150/ijbs.58791.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.58791</ArticleId><ArticleId IdType="pmc">PMC8071761</ArticleId><ArticleId IdType="pubmed">33907513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratofil RM, Kubes P, Deniset JF. Monocyte Conversion During Inflammation and Injury. Arterioscler. Thromb. Vasc. Biol. 2017;37:35&#x2013;42. doi: 10.1161/ATVBAHA.116.308198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.116.308198</ArticleId><ArticleId IdType="pubmed">27765768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell AJ, Roediger B, Weninger W. Monocyte homeostasis and the plasticity of inflammatory monocytes. Cell. Immunol. 2014;291:22&#x2013;31. doi: 10.1016/j.cellimm.2014.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2014.05.010</ArticleId><ArticleId IdType="pubmed">24962351</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann C, et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat. Commun. 2021;12:3406. doi: 10.1038/s41467-021-23494-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23494-1</ArticleId><ArticleId IdType="pmc">PMC8184784</ArticleId><ArticleId IdType="pubmed">34099652</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J. Clin. Invest. 2021;131:e148635. doi: 10.1172/JCI148635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148635</ArticleId><ArticleId IdType="pmc">PMC8245177</ArticleId><ArticleId IdType="pubmed">34196300</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes M, et al. An immune-cell signature of bacterial sepsis. Nat. Med. 2020;26:333&#x2013;340. doi: 10.1038/s41591-020-0752-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0752-4</ArticleId><ArticleId IdType="pmc">PMC7235950</ArticleId><ArticleId IdType="pubmed">32066974</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes M, et al. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Sci. Transl. Med. 2021;13:eabe9599. doi: 10.1126/scitranslmed.abe9599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe9599</ArticleId><ArticleId IdType="pmc">PMC8432955</ArticleId><ArticleId IdType="pubmed">34103408</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women. Diabetologia. 2018;61:2549&#x2013;2560. doi: 10.1007/s00125-018-4733-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4733-9</ArticleId><ArticleId IdType="pmc">PMC6309828</ArticleId><ArticleId IdType="pubmed">30306190</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin and Autoimmunity. Front. Immunol. 2018;9:73. doi: 10.3389/fimmu.2018.00073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00073</ArticleId><ArticleId IdType="pmc">PMC5816039</ArticleId><ArticleId IdType="pubmed">29483903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong T, Zhi L, Bhayana B, Wu MX. Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. J. Neuroinflammation. 2016;13:197. doi: 10.1186/s12974-016-0663-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0663-y</ArticleId><ArticleId IdType="pmc">PMC5000452</ArticleId><ArticleId IdType="pubmed">27561600</ArticleId></ArticleIdList></Reference><Reference><Citation>Das C, Rout MK, Wildering WC, Vijayan MM. Cortisol modulates calcium release-activated calcium channel gating in fish hepatocytes. Sci. Rep. 2021;11:9621. doi: 10.1038/s41598-021-88957-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88957-3</ArticleId><ArticleId IdType="pmc">PMC8100157</ArticleId><ArticleId IdType="pubmed">33953236</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer IE, et al. Cortisol Response in Relation to the Severity of Stress and Illness. J. Clin. Endocrinol. Metab. 2005;90:4579&#x2013;4586. doi: 10.1210/jc.2005-0354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2005-0354</ArticleId><ArticleId IdType="pubmed">15886236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawohl W, Nordt C. COVID-19, unemployment, and suicide. Lancet Psychiatry. 2020;7:389&#x2013;390. doi: 10.1016/S2215-0366(20)30141-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30141-3</ArticleId><ArticleId IdType="pmc">PMC7185950</ArticleId><ArticleId IdType="pubmed">32353269</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J. Affect. Disord. 2020;277:55&#x2013;64. doi: 10.1016/j.jad.2020.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7413844</ArticleId><ArticleId IdType="pubmed">32799105</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv,10.1101/2022.08.09.22278592 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandel A, et al. Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation. J. Intensive Care Med. 2021;36:689&#x2013;695. doi: 10.1177/0885066621997039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066621997039</ArticleId><ArticleId IdType="pmc">PMC8145413</ArticleId><ArticleId IdType="pubmed">33641491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzeffi MA, Chow JH, Tanaka K. COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management. Shock. 2021;55:465&#x2013;471. doi: 10.1097/SHK.0000000000001660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001660</ArticleId><ArticleId IdType="pmc">PMC7959868</ArticleId><ArticleId IdType="pubmed">32890309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kichloo A, et al. COVID-19 and Hypercoagulability: A Review. Clin. Appl. Thromb. Hemost. 2020;26:1076029620962853. doi: 10.1177/1076029620962853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620962853</ArticleId><ArticleId IdType="pmc">PMC7592310</ArticleId><ArticleId IdType="pubmed">33074732</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Ten Cate H. Disseminated intravascular coagulation. N. Engl. J. Med. 1999;341:586&#x2013;592. doi: 10.1056/NEJM199908193410807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199908193410807</ArticleId><ArticleId IdType="pubmed">10451465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, et al. Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian W, et al. Immune suppression in the early stage of COVID-19 disease. Nat. Commun. 2020;11:5859. doi: 10.1038/s41467-020-19706-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19706-9</ArticleId><ArticleId IdType="pmc">PMC7673112</ArticleId><ArticleId IdType="pubmed">33203833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi P, et al. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India. Viral Immunol. 2023;36:163&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">36897333</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol. 2021;113:45&#x2013;57. doi: 10.1007/s12185-020-03029-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-020-03029-y</ArticleId><ArticleId IdType="pmc">PMC7648664</ArticleId><ArticleId IdType="pubmed">33161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera. Cell Discov. 2022;8:110. doi: 10.1038/s41421-022-00472-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00472-5</ArticleId><ArticleId IdType="pmc">PMC9557992</ArticleId><ArticleId IdType="pubmed">36229428</ArticleId></ArticleIdList></Reference><Reference><Citation>Quandt J, et al. Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes. Sci. Immunol. 2022;7:eabq2427. doi: 10.1126/sciimmunol.abq2427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abq2427</ArticleId><ArticleId IdType="pmc">PMC9162083</ArticleId><ArticleId IdType="pubmed">35653438</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JP, et al. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci. Transl. Med. 2022;14:eabn8057. doi: 10.1126/scitranslmed.abn8057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn8057</ArticleId><ArticleId IdType="pmc">PMC8939766</ArticleId><ArticleId IdType="pubmed">35166573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachmann NP, et al. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. N. Engl. J. Med. 2022;387:86&#x2013;88. doi: 10.1056/NEJMc2206576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2206576</ArticleId><ArticleId IdType="pmc">PMC9258748</ArticleId><ArticleId IdType="pubmed">35731894</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu P, et al. Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants. N. Engl. J. Med. 2022;386:2526&#x2013;2528. doi: 10.1056/NEJMc2206725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2206725</ArticleId><ArticleId IdType="pmc">PMC9258774</ArticleId><ArticleId IdType="pubmed">35704428</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu P, et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe. 2023;31:9&#x2013;17.e3. doi: 10.1016/j.chom.2022.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.11.012</ArticleId><ArticleId IdType="pmc">PMC9678813</ArticleId><ArticleId IdType="pubmed">36476380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, et al. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients&#x2019; B Cells. Cell. 2020;182:73&#x2013;84.e16. doi: 10.1016/j.cell.2020.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7231725</ArticleId><ArticleId IdType="pubmed">32425270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184:1895&#x2013;1913.e19. doi: 10.1016/j.cell.2021.01.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.053</ArticleId><ArticleId IdType="pmc">PMC7857060</ArticleId><ArticleId IdType="pubmed">33657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595:107&#x2013;113. doi: 10.1038/s41586-021-03570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Hui A. Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine. Life. 2022;12:57. doi: 10.3390/life12010057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12010057</ArticleId><ArticleId IdType="pmc">PMC8780073</ArticleId><ArticleId IdType="pubmed">35054450</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, et al. 3&#x2019;UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling. Front. Immunol. 2022;13:924667. doi: 10.3389/fimmu.2022.924667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.924667</ArticleId><ArticleId IdType="pmc">PMC9552351</ArticleId><ArticleId IdType="pubmed">36238276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, et al. Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines. N. Engl. J. Med. 2022;387:277&#x2013;280. doi: 10.1056/NEJMc2206900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2206900</ArticleId><ArticleId IdType="pmc">PMC9342420</ArticleId><ArticleId IdType="pubmed">35793198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, et al. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant. N. Engl. J. Med. 2022;386:894&#x2013;896. doi: 10.1056/NEJMc2119426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2119426</ArticleId><ArticleId IdType="pmc">PMC8809506</ArticleId><ArticleId IdType="pubmed">35081296</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, et al. Synergistic effects of mechanical stimulation and crimped topography to stimulate natural collagen development for tendon engineering. Acta Biomater. 2022;145:297&#x2013;315. doi: 10.1016/j.actbio.2022.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2022.04.026</ArticleId><ArticleId IdType="pubmed">35470072</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, et al. The anti-aging effects of Renshen Guben on thyrotoxicosis mice: Improving immunosenescence, hypoproteinemia, lipotoxicity, and intestinal flora. Front. Immunol. 2022;13:983501. doi: 10.3389/fimmu.2022.983501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.983501</ArticleId><ArticleId IdType="pmc">PMC9640368</ArticleId><ArticleId IdType="pubmed">36389720</ArticleId></ArticleIdList></Reference><Reference><Citation>Dann E, Henderson NC, Teichmann SA, Morgan MD, Marioni JC. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 2022;40:245&#x2013;253. doi: 10.1038/s41587-021-01033-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01033-z</ArticleId><ArticleId IdType="pubmed">34594043</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics Proteom. Bioinforma. 2021;19:578&#x2013;583. doi: 10.1016/j.gpb.2021.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2021.08.001</ArticleId><ArticleId IdType="pmc">PMC9039563</ArticleId><ArticleId IdType="pubmed">34400360</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>